2008 News

Cardiovascular Sciences, Inc. Secures Funding to Accelerate Development of Novel Anti-Adhesion Technology

ORLANDO, FL (January 03, 2008) Cardiovascular Sciences, Inc. (CVSC), announces a capital investment from Seven Palm Investments, LLC of Illinois.  The funding will support continued development of the company’s primary technology for prevention of adhesions following surgery.  Adhesions occur any time two adjacent tissues have been injured as part of the normal healing process.  For cuts on the surface of the skin, this is a good thing.  But when it is between two internal organs or tissue surfaces that are not usually fused, it can cause clinically significant and serious problems. 

“We feel that we have developed a novel and exciting approach to a problem that plagues all surgeries and can be clinically significant in up to a quarter of all surgical patients,” explains Dr. Larry Hooper, the company’s CEO. 

Cardiovascular has partnered with the University of Central Florida, Department of Chemistry to develop the technology.  The first arm of development has produced several formulations of material with promising anti-adhesive properties. Early results indicate the material overcomes some of the problems that exist with current products on the market. A six figure matching grant from the Florida High Tech Corridor Council last year enabled the company to start degradation studies ahead of schedule. 

“The investment from Seven Palms will allow us to rapidly accelerate the pace of development of this promising technology and enter the marketplace within the next 2 years.” stated Dr. Hooper.  “We have entered a new stage in our corporate growth.” 

Concurrent with this, the Company’s website has gone live at www.cvsciences.org.  The website provides current information about the company and the field of technology.

Cardiovascular Sciences is a client of the UCF Technology Incubator. 
Dr. Larry Hooper, Cardiovascular Sciences 407-208-9943
Tom O’Neal or Carol Ann Dykes, UCF Technology Incubator 407-882-0202
Larry Vershel, Larry Vershel Communications 407-644-4142 or 386-837-8780  

About Cardiovascular Sciences, Inc.
Based in Orlando, Florida, Cardiovascular Sciences Inc. is a technology company focused on the development of innovative medical products. Cardiovascular Sciences is currently developing proprietary technology for the prevention of post-surgical adhesions. Adhesions are fibrous scar tissue formations that develop between tissues or organs following trauma, or the insult to tissues and organs associated with virtually any surgical procedure. The currently available techniques, methods, and products used in treatment of these indications are usually no more than 50% effective. Cardiovascular Sciences, Inc.’s novel anti-adhesion products are being developed to be more effective, easier to handle, and much less costly than those currently on the market.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular when used in the preceding discussion, the words believes, expects, intends, will, anticipated or may and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties including, without limitation, risks associated with operations, availability of capital on a reasonable term, the effects of government regulations and operations risks.

SOURCE Cardiovascular Sciences, Inc.; 3251 Progress Dr., #A-107; Orlando, FL   32826

About the UCF Technology Incubator
The UCF Technology Incubator is part of the UCF Incubator Network.  Since its founding in 1999, the UCF Technology Incubator has helped more than 90 emerging technology companies create over $200 million in annual revenue and more than 800 new jobs with an average salary of $59,000. The UCF Technology Incubator was named 2004 Incubator of the Year by the National Business Incubation Association. Headquartered in Research Park near the University, the Incubator is a true collaboration in economic development between UCF, Orange County, the City of Orlando, the Florida High Tech Corridor Council and the Metro Orlando Economic Development Commission. For more information, please visit www.incubator.ucf.edu.

 

www.ucf.edu